This content is from:Opinion Private Credit Is a Driver, Not a Drug, of the American Economy A response to attacks on private credit markets. ByDrew Maloney February 12, 2020
This content is from:Premium The Hedge Funds Poised to Profit From a Drug Maker’s IPO At least four hedge funds own nearly half of the shares of the latest biopharma company planning to go public. BySteve Taub August 22, 2019
This content is from:Premium Citadel’s Quiet Drug Fix The hedge fund firm has been quietly making private investments in biopharma. BySteve Taub August 30, 2019
This content is from:Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. ByStephen Taub December 08, 2020
This content is from:Premium The Stocks That Drove Glenview’s Major Comeback Larry Robbins’ hedge fund finished 2020 solidly positive thanks to huge gains in the final two months of the year. ByStephen Taub January 04, 2021
This content is from:www.yabo88.com Oxford University Has a Shot at Vaccine Billions. Or Does It? Inside the competitive, turbulent, and morally fraught race to capitalize on a Covid-19 vaccine. ByAmy Whyte September 23, 2020
